API Holdings, the parent company of online pharmacy PharmEasy, announced last week that it would pick up a 66.1 per cent stake in diagnostics firm Thyrocare for Rs 4,546 crore. It is the first unicorn to acquire a listed company.

• Cupid Hits Fresh 52-Week High on Rs 128 Crore Block Deal
• Ather Energy Slips Despite $200 Million Fundraise Buzz
• Shyam Metalics Slips Even as Q1 Volumes Surge
• Unihealth Hospitals Shares Hit 5% Upper Circuit on Plans to Raise Stake 
• Oswal Pumps, Shakti Pumps Rally on Solar Order Wins

One of the most extensive consolidations in the domestic health care space, the deal was struck in record time at the Mumbai residence of A Velumani, founder of Thyrocare. The deal is also a milestone for five friends from the Mumbai suburb of Ghatkopar, who called themselves the Ghatkopar Gujju gang and set up PharmEasy in 2015.